Generic diabetes pill matches brand in healthy volunteer test

NCT ID NCT07479108

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a generic version of empagliflozin (25 mg) works the same as the brand-name drug Jardiance® in 32 healthy adults. Participants took a single dose of each tablet under fasting conditions, and researchers measured drug levels in the blood to check for bioequivalence. The goal was to ensure the generic is a safe and effective alternative.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOEQUIVALANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • FS Scientia Pharma

    San Luis Potosí City, San Luis Potosí, 78270, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.